Id |
Subject |
Object |
Predicate |
Lexical cue |
ForCovid19 |
Memo |
correct/standard/original word |
tao:has_database_id |
typo |
7 |
0-4 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T93 |
5-12 |
Induce |
denotes |
induces |
|
|
|
|
|
8 |
13-26 |
Biological |
denotes |
throboxane-A2 |
|
|
|
MESH:D013928 |
|
9 |
28-32 |
Biological |
denotes |
TxA2 |
|
|
|
MESH:D013928 |
|
10 |
37-45 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
11 |
54-66 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
T1 |
71-84 |
Disease |
denotes |
micro-thrombi |
|
|
|
|
|
T95 |
86-96 |
Negative |
denotes |
inhibitory |
|
|
|
|
|
T94 |
97-103 |
Result |
denotes |
effect |
|
|
|
|
|
12 |
111-135 |
Gene |
denotes |
IL-1 receptor antagonist |
|
|
|
Gene:3557 |
|
13 |
137-143 |
Gene |
denotes |
IL-1Ra |
|
|
|
Gene:3557 |
|
89 |
146-150 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T96 |
151-158 |
Induce |
denotes |
induces |
|
|
|
|
|
T4 |
183-192 |
Biological |
denotes |
metabolic |
|
|
|
|
|
T3 |
197-210 |
Biological |
denotes |
hematological |
|
|
|
|
|
T2 |
211-218 |
Change |
denotes |
changes |
|
|
|
|
|
T97 |
223-243 |
Species |
denotes |
experimental animals |
|
|
|
|
|
T99 |
245-249 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T7 |
250-260 |
Therapy |
denotes |
treatments |
|
|
|
|
|
91 |
267-278 |
Disease |
denotes |
hypotension |
|
|
|
MESH:D007022 |
|
T101 |
286-291 |
Severity |
denotes |
rapid |
|
|
|
|
|
T100 |
292-301 |
Decrease |
denotes |
reduction |
|
|
|
|
|
T5 |
305-328 |
Biological |
denotes |
systemic blood pressure |
|
|
|
|
|
T102 |
330-337 |
Decrease |
denotes |
reduced |
|
|
|
|
|
T6 |
338-357 |
Biological |
denotes |
vascular resistance |
|
|
|
|
|
T103 |
359-368 |
Increase |
denotes |
increased |
|
|
|
|
|
T8 |
369-379 |
Biological |
denotes |
heart rate |
|
|
|
|
|
T9 |
384-406 |
Biological |
denotes |
leukocyte aggregations |
|
|
|
|
|
92 |
408-412 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
93 |
420-443 |
Disease |
denotes |
endothelial dysfunction |
|
|
|
MESH:C536439 |
|
T105 |
515-523 |
Species |
denotes |
pathogen |
|
|
|
|
|
T104 |
524-533 |
Disease |
denotes |
infection |
|
|
|
MESH:D007239 |
|
T12 |
535-551 |
Disease |
denotes |
This dysfunction |
|
|
|
MESH:C536439 |
|
T15 |
568-578 |
Biological |
denotes |
macrophage |
|
|
|
|
|
T108 |
579-591 |
Function |
denotes |
intervention |
|
|
|
|
|
T16 |
596-605 |
Increase |
denotes |
increased |
|
|
|
|
|
T106 |
606-613 |
Biological |
denotes |
protein |
|
|
|
|
|
T107 |
614-626 |
Property |
denotes |
permeability |
|
|
|
MESH:D010539 |
|
T13 |
673-682 |
Biological |
denotes |
cytokines |
|
|
|
|
|
T14 |
687-712 |
Biological |
denotes |
arachidonic acid products |
|
|
|
|
|
T114 |
714-719 |
Disease |
denotes |
These |
|
|
|
|
|
T113 |
720-727 |
Result |
denotes |
effects |
|
|
|
|
|
T112 |
746-755 |
Induce |
denotes |
induction |
|
|
|
|
|
96 |
759-763 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T111 |
767-786 |
Disease |
denotes |
various pathologies |
|
|
|
|
|
T110 |
814-830 |
Species |
denotes |
pathogenic viral |
|
|
|
|
|
T109 |
831-841 |
Disease |
denotes |
infections |
|
|
|
MESH:D007239 |
|
98 |
853-863 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
|
99 |
879-887 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
T115 |
889-899 |
Activate |
denotes |
Activation |
|
|
|
|
|
T116 |
903-914 |
Biological |
denotes |
macrophages |
|
|
|
|
|
100 |
918-932 |
Species |
denotes |
coronavirus-19 |
|
|
|
Tax:2697049 |
|
T17 |
946-953 |
Increase |
denotes |
release |
|
|
|
|
|
T18 |
957-973 |
Type |
denotes |
pro-inflammatory |
|
|
|
|
|
T117 |
974-983 |
Biological |
denotes |
cytokines |
|
|
|
|
|
T19 |
985-1003 |
Biological |
denotes |
metalloproteinases |
|
|
|
|
|
T20 |
1008-1033 |
Biological |
denotes |
other proteolytic enzymes |
|
|
|
|
|
T22 |
1049-1066 |
Disease |
denotes |
thrombi formation |
|
|
|
|
|
T21 |
1071-1077 |
Severity |
denotes |
severe |
|
|
|
|
|
101 |
1078-1101 |
Disease |
denotes |
respiratory dysfunction |
|
|
|
MESH:D012131 |
|
102 |
1103-1111 |
Species |
denotes |
Patients |
|
|
|
Tax:9606 |
|
103 |
1117-1125 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
T23 |
1127-1140 |
Severity |
denotes |
seriously ill |
|
|
|
|
|
T118 |
1145-1175 |
Severity |
denotes |
hospitalized in intensive care |
|
|
|
|
|
T119 |
1177-1184 |
Show |
denotes |
present |
|
|
|
|
|
T24 |
1185-1193 |
Severity |
denotes |
systemic |
|
|
|
|
|
104 |
1194-1206 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
105 |
1208-1234 |
Disease |
denotes |
intravascular coagulopathy |
|
|
|
MESH:D004211 |
|
T25 |
1240-1249 |
BecomeSevere |
denotes |
high risk |
|
|
|
|
|
106 |
1253-1277 |
Disease |
denotes |
thrombotic complications |
|
|
|
MESH:D013927 |
|
107 |
1283-1305 |
Disease |
denotes |
venous thromboembolism |
|
|
|
MESH:D054556 |
|
108 |
1334-1338 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T120 |
1343-1348 |
Disease |
denotes |
these |
|
|
|
|
|
109 |
1349-1357 |
Species |
denotes |
patients |
|
|
|
Tax:9606 |
|
T26 |
1362-1367 |
Biological |
denotes |
lungs |
|
|
|
|
|
T122 |
1390-1402 |
Target |
denotes |
target organ |
|
|
|
|
|
T121 |
1424-1432 |
Increase |
denotes |
increase |
|
|
|
|
|
T30 |
1440-1460 |
Biological |
denotes |
degradation products |
|
|
|
|
|
T31 |
1464-1470 |
Biological |
denotes |
fibrin |
|
|
|
|
|
110 |
1472-1482 |
Gene |
denotes |
fibrinogen |
|
|
|
Gene:2244 |
|
T28 |
1487-1494 |
Biological |
denotes |
D-dimer |
|
|
|
MESH:C036309 |
|
T27 |
1501-1514 |
Disease |
denotes |
organ lesions |
|
|
|
|
|
111 |
1519-1538 |
Disease |
denotes |
respiratory failure |
|
|
|
MESH:D012131 |
|
112 |
1562-1566 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T123 |
1567-1574 |
Induce |
denotes |
induces |
|
|
|
|
|
T125 |
1575-1581 |
Gene |
denotes |
itself |
|
|
|
Gene:3552 |
|
T126 |
1609-1625 |
Type |
denotes |
pro-inflammatory |
|
|
|
|
|
T32 |
1626-1634 |
Biological |
denotes |
cytokine |
|
|
|
|
|
113 |
1636-1639 |
Gene |
denotes |
TNF |
|
|
|
Gene:7124 |
|
114 |
1698-1712 |
Disease |
denotes |
shock syndrome |
|
|
|
MESH:D012769 |
|
115 |
1716-1724 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
116 |
1731-1735 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
117 |
1740-1743 |
Gene |
denotes |
TNF |
|
|
|
Gene:7124 |
|
118 |
1750-1765 |
Disease |
denotes |
pulmonary edema |
|
|
|
MESH:D011654 |
|
T34 |
1767-1777 |
Disease |
denotes |
thrombosis |
|
|
|
MESH:D013927 |
|
T36 |
1782-1790 |
Disease |
denotes |
bleeding |
|
|
|
MESH:D006470 |
|
120 |
1807-1818 |
Disease |
denotes |
hypotension |
|
|
|
MESH:D007022 |
|
T37 |
1823-1860 |
Disease |
denotes |
resistance of systemic blood pressure |
|
May be "http://purl.obolibrary.org/obo/HP_0030972". |
|
|
|
121 |
1862-1866 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
122 |
1874-1884 |
Disease |
denotes |
leukopenia |
|
|
|
MESH:D007970 |
|
123 |
1889-1905 |
Disease |
denotes |
thrombocytopenia |
|
|
|
MESH:D013921 |
|
T38 |
1911-1931 |
Disease |
denotes |
formation of thrombi |
|
|
|
|
|
T127 |
1944-1956 |
Disease |
denotes |
complication |
comorbidity |
|
|
|
|
T128 |
1964-1982 |
Biological |
denotes |
circulatory system |
|
|
|
|
|
T129 |
1987-2000 |
Function |
denotes |
functionality |
|
|
|
|
|
T130 |
2008-2013 |
Biological |
denotes |
organ |
|
|
|
|
|
T42 |
2052-2061 |
Index |
denotes |
morbidity |
|
|
|
MESH:D009017 |
|
124 |
2066-2075 |
Die |
denotes |
mortality |
|
|
|
MESH:D009026 |
|
125 |
2077-2081 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T131 |
2089-2097 |
Biological |
denotes |
platelet |
|
|
|
|
|
T132 |
2098-2106 |
Biological |
denotes |
vascular |
|
|
|
|
|
T133 |
2107-2122 |
Function |
denotes |
thrombogenicity |
|
|
|
|
|
T43 |
2131-2152 |
Biological |
denotes |
non-endothelial cells |
|
|
|
|
|
T135 |
2156-2167 |
Induce |
denotes |
stimulating |
|
|
|
|
|
T134 |
2172-2181 |
Function |
denotes |
formation |
|
|
|
|
|
127 |
2185-2199 |
Biological |
denotes |
thromboxane A2 |
|
|
|
MESH:D013928 |
|
T136 |
2209-2217 |
Release |
denotes |
released |
|
|
|
|
|
T44 |
2227-2247 |
Biological |
denotes |
inflamed environment |
|
|
|
|
|
128 |
2249-2253 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T137 |
2295-2303 |
Induce |
denotes |
inducing |
|
|
|
|
|
129 |
2304-2309 |
Disease |
denotes |
fever |
|
|
|
MESH:D005334 |
|
T139 |
2339-2349 |
Metabolism |
denotes |
metabolism |
|
|
|
|
|
130 |
2353-2369 |
Biological |
denotes |
arachidonic acid |
|
|
|
MESH:D016718 |
|
T138 |
2376-2385 |
Chemical |
denotes |
increases |
|
|
|
|
|
T46 |
2391-2418 |
Biological |
denotes |
vascular endothelial organs |
|
|
|
|
|
T45 |
2426-2438 |
Biological |
denotes |
hypothalamus |
|
|
|
|
|
132 |
2460-2470 |
Disease |
denotes |
thrombosis |
|
|
|
MESH:D013927 |
|
T51 |
2472-2480 |
Biological |
denotes |
vascular |
|
|
|
|
|
133 |
2481-2493 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
T49 |
2498-2509 |
Biological |
denotes |
angigenesis |
|
|
angiogenesis |
|
t |
T50 |
2540-2550 |
Activate |
denotes |
activation |
|
|
|
|
|
T47 |
2569-2592 |
Gene |
denotes |
thromboxane A2 receptor |
|
|
|
Gene:6915 |
|
T68 |
2697-2705 |
Condition |
denotes |
In vitro |
|
|
|
|
|
T141 |
2706-2714 |
Increase |
denotes |
enhanced |
|
|
|
|
|
134 |
2715-2729 |
Chemical |
denotes |
thromboxane B2 |
|
|
|
MESH:D013929 |
|
T140 |
2730-2737 |
Release |
denotes |
release |
|
|
|
|
|
T62 |
2741-2769 |
Biological |
denotes |
polymorphonuclear leukocytes |
|
|
|
|
|
T61 |
2774-2785 |
Biological |
denotes |
macrophages |
|
|
|
|
|
135 |
2807-2812 |
Species |
denotes |
human |
|
|
|
Tax:9606 |
|
T58 |
2813-2824 |
Recombinant |
denotes |
recombinant |
|
|
|
|
|
T57 |
2825-2838 |
Gene |
denotes |
interleukin 1 |
|
|
|
Gene:3552 |
|
137 |
2915-2919 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T142 |
2920-2927 |
Induce |
denotes |
induces |
|
|
|
|
|
138 |
2928-2942 |
Biological |
denotes |
thromboxane B2 |
|
|
|
MESH:D013929 |
|
139 |
2944-2948 |
Biological |
denotes |
TxB2 |
|
|
|
MESH:D013929 |
|
T143 |
2950-2958 |
Release |
denotes |
releases |
|
|
|
|
|
T52 |
2962-2971 |
Activate |
denotes |
activated |
|
|
|
|
|
T53 |
2972-2983 |
Biological |
denotes |
neutrophils |
|
|
|
|
|
T54 |
2988-2999 |
Biological |
denotes |
macrophages |
|
|
|
|
|
T146 |
3004-3012 |
Increase |
denotes |
increase |
|
|
|
|
|
140 |
3016-3027 |
Chemical |
denotes |
thromboxane |
|
|
|
MESH:D013931 |
|
T145 |
3032-3038 |
Induce |
denotes |
induce |
|
|
|
|
|
T144 |
3039-3060 |
Biological |
denotes |
leukocyte aggregation |
|
|
|
|
|
T64 |
3065-3073 |
Severity |
denotes |
systemic |
|
|
|
|
|
141 |
3074-3086 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
T65 |
3116-3124 |
Severity |
denotes |
dramatic |
|
|
|
|
|
T39 |
3125-3142 |
Disease |
denotes |
thrombi formation |
|
|
|
|
|
142 |
3147-3164 |
Disease |
denotes |
organ dysfunction |
|
|
|
MESH:D009102 |
|
143 |
3173-3177 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T147 |
3178-3188 |
Induce |
denotes |
stimulates |
|
|
|
|
|
T148 |
3189-3205 |
Biological |
denotes |
endothelial cell |
|
|
|
|
|
T149 |
3206-3215 |
Biological |
denotes |
leukocyte |
|
|
|
|
|
T66 |
3216-3224 |
Bind |
denotes |
adhesion |
|
|
|
|
|
T150 |
3230-3234 |
Biological |
denotes |
TxB2 |
|
|
|
MESH:D013929 |
|
T151 |
3235-3245 |
Produce |
denotes |
production |
|
|
|
|
|
T155 |
3291-3299 |
Increase |
denotes |
increase |
|
|
|
|
|
T69 |
3303-3314 |
Biological |
denotes |
neutrophils |
|
|
|
|
|
T156 |
3320-3326 |
Bind |
denotes |
adhere |
|
|
|
|
|
T154 |
3334-3338 |
Biological |
denotes |
lung |
|
|
|
|
|
T153 |
3347-3355 |
Decrease |
denotes |
decrease |
|
|
|
|
|
T70 |
3359-3370 |
Biological |
denotes |
lymphocytes |
|
|
|
|
|
144 |
3383-3393 |
Biological |
denotes |
ecosanoids |
|
|
|
|
|
145 |
3402-3406 |
Biological |
denotes |
TxA2 |
|
|
|
MESH:D013928 |
|
T159 |
3408-3416 |
Detect |
denotes |
detected |
|
|
|
|
|
T152 |
3420-3424 |
Biological |
denotes |
TxB2 |
|
|
|
MESH:D013929 |
|
T71 |
3452-3460 |
Biological |
denotes |
vascular |
|
|
|
|
|
146 |
3461-3473 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
147 |
3478-3498 |
Biological |
denotes |
platelet aggregation |
|
|
|
|
|
T157 |
3514-3523 |
Produce |
denotes |
formation |
|
|
|
|
|
T40 |
3527-3534 |
Biological |
denotes |
thrombi |
|
|
|
|
|
T74 |
3540-3554 |
Biological |
denotes |
thrombogenesis |
|
May be MESH:D013927? |
|
|
|
148 |
3570-3578 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
T75 |
3588-3596 |
Biological |
denotes |
platelet |
|
|
|
|
|
T158 |
3601-3617 |
Biological |
denotes |
cell aggregation |
|
|
|
|
|
T76 |
3606-3617 |
Biological |
denotes |
aggregation |
|
|
|
|
|
149 |
3623-3645 |
Biological |
denotes |
clotting abnormalities |
|
|
|
|
|
T78 |
3651-3681 |
Chemical |
denotes |
anti-clotting inhibitor agents |
inhibitor|drug |
|
|
|
|
T160 |
3698-3708 |
Prevent |
denotes |
prevention |
|
|
|
|
|
150 |
3724-3743 |
Disease |
denotes |
thrombotic diseases |
|
|
|
MESH:D013927 |
|
T162 |
3745-3755 |
Prevent |
denotes |
Prevention |
|
|
|
|
|
T163 |
3762-3771 |
Induce |
denotes |
induction |
|
|
|
|
|
T73 |
3775-3779 |
Biological |
denotes |
TxA2 |
|
|
|
MESH:D013928 |
|
T164 |
3780-3786 |
Prevent |
denotes |
avoids |
|
|
|
|
|
T41 |
3787-3804 |
Biological |
denotes |
thrombi formation |
|
|
|
|
|
T161 |
3805-3812 |
Induce |
denotes |
induced |
|
|
|
|
|
151 |
3816-3820 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T172 |
3839-3846 |
Severity |
denotes |
serious |
|
|
|
|
|
T171 |
3847-3862 |
Biological |
denotes |
vascular events |
|
|
|
|
|
152 |
3869-3873 |
Biological |
denotes |
TxA2 |
|
|
|
MESH:D013928 |
|
T84 |
3874-3883 |
Increase |
denotes |
increases |
|
|
|
|
|
T83 |
3884-3897 |
Severity |
denotes |
significantly |
|
|
|
|
|
T165 |
3905-3914 |
Difficult |
denotes |
difficult |
|
|
|
|
|
T166 |
3918-3925 |
Prevent |
denotes |
inhibit |
|
|
|
|
|
T173 |
3950-3961 |
Easy |
denotes |
much better |
|
|
|
|
|
T167 |
3965-3972 |
Prevent |
denotes |
prevent |
|
|
|
|
|
T168 |
3977-3986 |
Induce |
denotes |
induction |
|
|
|
|
|
T169 |
3991-4001 |
Produce |
denotes |
generation |
|
|
|
|
|
T82 |
4005-4013 |
Prevent |
denotes |
blocking |
|
|
|
|
|
T170 |
4018-4027 |
Induce |
denotes |
inductors |
|
|
|
|
|
153 |
4038-4042 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T86 |
4048-4058 |
Prevent |
denotes |
inhibition |
|
|
|
|
|
T87 |
4062-4066 |
Cleave |
denotes |
lack |
|
|
|
|
|
T85 |
4070-4079 |
Structure |
denotes |
formation |
|
|
|
|
|
154 |
4083-4087 |
Gene |
denotes |
IL-1 |
|
|
|
Gene:3552 |
|
T174 |
4088-4094 |
Prevent |
denotes |
avoids |
|
|
|
|
|
155 |
4147-4152 |
Die |
denotes |
death |
|
|
|
MESH:D003643 |
|
156 |
4160-4167 |
Species |
denotes |
patient |
|
|
|
Tax:9606 |
|
T178 |
4173-4182 |
Therapy |
denotes |
treatment |
|
|
|
|
|
T175 |
4186-4205 |
Biological |
denotes |
innate immune cells |
|
|
|
|
|
T176 |
4206-4215 |
Produce |
denotes |
producing |
|
|
|
|
|
157 |
4216-4220 |
Gene |
denotes |
IL-1 |
negative |
|
|
Gene:3552 |
|
158 |
4226-4250 |
Gene |
denotes |
IL-1 receptor antagonist |
inhibitor |
|
|
Gene:3557 |
|
159 |
4252-4258 |
Gene |
denotes |
IL-1Ra |
inhibitor |
|
|
Gene:3557 |
|
T177 |
4264-4269 |
Prevent |
denotes |
avoid |
|
|
|
|
|
T90 |
4270-4289 |
Biological |
denotes |
hemodynamic changes |
|
|
|
|
|
160 |
4291-4303 |
Disease |
denotes |
septic shock |
|
|
|
MESH:D012772 |
|
T88 |
4308-4313 |
Biological |
denotes |
organ |
|
|
|
|
|
161 |
4314-4326 |
Disease |
denotes |
inflammation |
|
|
|
MESH:D007249 |
|
162 |
4373-4381 |
Disease |
denotes |
COVID-19 |
|
|
|
MESH:C000657245 |
|
163 |
4393-4403 |
Species |
denotes |
SARS-CoV-2 |
|
|
|
Tax:2697049 |
|
R1 |
T4 |
T2 |
of_a |
metabolic,changes |
R100 |
12 |
T94 |
of_a |
IL-1 receptor antagonist,effect |
R101 |
13 |
12 |
abbreviation |
IL-1Ra,IL-1 receptor antagonist |
R102 |
89 |
T96 |
is_a |
IL-1,induces |
R103 |
T96 |
T2 |
is_a |
induces,changes |
R104 |
T3 |
T2 |
of_a |
hematological,changes |
R105 |
T99 |
T7 |
of_a |
IL-1,treatments |
R106 |
T101 |
T100 |
of_a |
rapid,reduction |
R107 |
T100 |
T5 |
is_a |
reduction,systemic blood pressure |
R108 |
T102 |
T6 |
is_a |
reduced,vascular resistance |
R109 |
T100 |
91 |
cause_of |
reduction,hypotension |
R110 |
T102 |
91 |
cause_of |
reduced,hypotension |
R111 |
T103 |
T8 |
is_a |
increased,heart rate |
R112 |
T103 |
T9 |
is_a |
increased,leukocyte aggregations |
R113 |
T103 |
91 |
cause_of |
increased,hypotension |
R114 |
T7 |
T100 |
cause_of |
treatments,reduction |
R115 |
T7 |
T102 |
cause_of |
treatments,reduced |
R116 |
T7 |
T103 |
of_a |
treatments,increased |
R117 |
T97 |
T7 |
for |
experimental animals,treatments |
R118 |
92 |
93 |
cause_of |
IL-1,endothelial dysfunction |
R119 |
T105 |
T104 |
of_a |
pathogen,infection |
R120 |
T12 |
93 |
coreference |
This dysfunction,endothelial dysfunction |
R121 |
T13 |
T12 |
relates |
cytokines,This dysfunction |
R122 |
T14 |
T12 |
relates |
arachidonic acid products,This dysfunction |
R123 |
T16 |
T107 |
is_a |
increased,permeability |
R124 |
T106 |
T107 |
of_a |
protein,permeability |
R125 |
T15 |
T108 |
of_a |
macrophage,intervention |
R126 |
T108 |
T12 |
is_a |
intervention,This dysfunction |
R127 |
T107 |
T12 |
is_a |
permeability,This dysfunction |
R128 |
T110 |
T109 |
by |
pathogenic viral,infections |
R129 |
98 |
99 |
by |
SARS-CoV-2,COVID-19 |
R130 |
T109 |
T111 |
is_a |
infections,various pathologies |
R131 |
99 |
T109 |
is_a |
COVID-19,infections |
R132 |
T114 |
T12 |
coreference |
These,This dysfunction |
R133 |
T114 |
T113 |
of_a |
These,effects |
R134 |
T111 |
T112 |
in |
various pathologies,induction |
R135 |
T112 |
T113 |
cause_of |
induction,effects |
R136 |
96 |
T112 |
of_a |
IL-1,induction |
R137 |
T17 |
T22 |
cause_of |
release,thrombi formation |
R138 |
T17 |
101 |
cause_of |
release,respiratory dysfunction |
R139 |
T115 |
T17 |
is_a |
Activation,release |
R140 |
T17 |
T117 |
is_a |
release,cytokines |
R141 |
T17 |
T20 |
is_a |
release,other proteolytic enzymes |
R142 |
T17 |
T19 |
is_a |
release,metalloproteinases |
R143 |
T115 |
T116 |
of_a |
Activation,macrophages |
R144 |
100 |
T115 |
by |
coronavirus-19,Activation |
R145 |
T21 |
101 |
of_a |
severe,respiratory dysfunction |
R146 |
103 |
102 |
has_a |
COVID-19,Patients |
R147 |
T23 |
103 |
of_a |
seriously ill,COVID-19 |
R148 |
T118 |
103 |
of_a |
hospitalized in intensive care,COVID-19 |
R149 |
T24 |
104 |
of_a |
systemic,inflammation |
R150 |
102 |
T119 |
is_a |
Patients,present |
R151 |
T119 |
104 |
is_a |
present,inflammation |
R152 |
T119 |
107 |
is_a |
present,venous thromboembolism |
R153 |
T119 |
105 |
is_a |
present,intravascular coagulopathy |
R154 |
105 |
T25 |
is_a |
intravascular coagulopathy,high risk |
R155 |
T25 |
106 |
is_a |
high risk,thrombotic complications |
R156 |
108 |
104 |
relates |
IL-1,inflammation |
R157 |
108 |
105 |
relates |
IL-1,intravascular coagulopathy |
R158 |
108 |
107 |
relates |
IL-1,venous thromboembolism |
R159 |
T120 |
109 |
has_a |
these,patients |
R160 |
T120 |
104 |
coreference |
these,inflammation |
R161 |
T120 |
105 |
coreference |
these,intravascular coagulopathy |
R162 |
T120 |
107 |
coreference |
these,venous thromboembolism |
R163 |
T31 |
T30 |
of_a |
fibrin,degradation products |
R164 |
110 |
T30 |
of_a |
fibrinogen,degradation products |
R165 |
T28 |
T30 |
of_a |
D-dimer,degradation products |
R166 |
T30 |
T121 |
is_a |
degradation products,increase |
R167 |
T26 |
T121 |
at |
lungs,increase |
R168 |
T26 |
109 |
of_a |
lungs,patients |
R169 |
T121 |
111 |
cause_of |
increase,respiratory failure |
R170 |
T121 |
T27 |
cause_of |
increase,organ lesions |
R171 |
T122 |
T26 |
is_a |
target organ,lungs |
R172 |
112 |
T123 |
is_a |
IL-1,induces |
R173 |
T123 |
T125 |
is_a |
induces,itself |
R174 |
T125 |
112 |
coreference |
itself,IL-1 |
R175 |
T123 |
113 |
is_a |
induces,TNF |
R176 |
T18 |
T117 |
of_a |
pro-inflammatory,cytokines |
R177 |
T126 |
T32 |
of_a |
pro-inflammatory,cytokine |
R178 |
T32 |
113 |
is_a |
cytokine,TNF |
R179 |
113 |
114 |
relates |
TNF,shock syndrome |
R180 |
115 |
114 |
in |
COVID-19,shock syndrome |
R181 |
T127 |
T38 |
is_a |
complication,formation of thrombi |
R182 |
T130 |
T129 |
of_a |
organ,functionality |
R183 |
T128 |
T127 |
of_a |
circulatory system,complication |
R184 |
T129 |
T127 |
of_a |
functionality,complication |
R185 |
127 |
T136 |
is_a |
thromboxane A2,released |
R186 |
T136 |
T44 |
into |
released,inflamed environment |
R187 |
127 |
T134 |
of_a |
thromboxane A2,formation |
R188 |
T135 |
T134 |
is_a |
stimulating,formation |
R189 |
125 |
T135 |
is_a |
IL-1,stimulating |
R190 |
T134 |
T133 |
is_a |
formation,thrombogenicity |
R191 |
T131 |
T133 |
of_a |
platelet,thrombogenicity |
R192 |
T132 |
T133 |
on |
vascular,thrombogenicity |
R193 |
T43 |
T133 |
on |
non-endothelial cells,thrombogenicity |
R195 |
T137 |
129 |
is_a |
inducing,fever |
R196 |
T45 |
T46 |
of_a |
hypothalamus,vascular endothelial organs |
R197 |
130 |
T138 |
is_a |
arachidonic acid,increases |
R198 |
T46 |
T138 |
from |
vascular endothelial organs,increases |
R199 |
130 |
T139 |
of_a |
arachidonic acid,metabolism |
R200 |
T139 |
T137 |
cause_of |
metabolism,inducing |
R201 |
128 |
T139 |
relates |
IL-1,metabolism |
R202 |
128 |
T137 |
is_a |
IL-1,inducing |
R203 |
T50 |
T49 |
cause_of |
activation,angigenesis |
R204 |
T51 |
133 |
of_a |
vascular,inflammation |
R205 |
T47 |
T50 |
of_a |
thromboxane A2 receptor,activation |
R206 |
139 |
138 |
abbreviation |
TxB2,thromboxane B2 |
R207 |
T58 |
T57 |
is_a |
recombinant,interleukin 1 |
R208 |
T57 |
135 |
of_a |
interleukin 1,human |
R209 |
134 |
T140 |
is_a |
thromboxane B2,release |
R210 |
T141 |
T140 |
is_a |
enhanced,release |
R211 |
T57 |
T140 |
cause_of |
interleukin 1,release |
R212 |
T62 |
T140 |
by |
polymorphonuclear leukocytes,release |
R213 |
T61 |
T140 |
by |
macrophages,release |
R214 |
T68 |
T140 |
of_a |
In vitro,release |
R215 |
137 |
T142 |
is_a |
IL-1,induces |
R216 |
T142 |
T143 |
is_a |
induces,releases |
R217 |
138 |
T143 |
is_a |
thromboxane B2,releases |
R218 |
T52 |
T54 |
is_a |
activated,macrophages |
R219 |
T52 |
T53 |
is_a |
activated,neutrophils |
R220 |
T52 |
T143 |
in |
activated,releases |
R221 |
T64 |
141 |
of_a |
systemic,inflammation |
R222 |
140 |
T146 |
is_a |
thromboxane,increase |
R223 |
T146 |
T145 |
is_a |
increase,induce |
R224 |
T145 |
T144 |
is_a |
induce,leukocyte aggregation |
R225 |
T145 |
141 |
is_a |
induce,inflammation |
R226 |
T65 |
T39 |
of_a |
dramatic,thrombi formation |
R227 |
T65 |
142 |
of_a |
dramatic,organ dysfunction |
R228 |
T144 |
T39 |
cause_of |
leukocyte aggregation,thrombi formation |
R229 |
T144 |
142 |
cause_of |
leukocyte aggregation,organ dysfunction |
R230 |
T64 |
T39 |
cause_of |
systemic,thrombi formation |
R231 |
141 |
142 |
cause_of |
inflammation,organ dysfunction |
R232 |
T149 |
T66 |
of_a |
leukocyte,adhesion |
R233 |
T148 |
T66 |
of_a |
endothelial cell,adhesion |
R234 |
143 |
T147 |
is_a |
IL-1,stimulates |
R235 |
T147 |
T66 |
is_a |
stimulates,adhesion |
R236 |
T147 |
T151 |
is_a |
stimulates,production |
R237 |
T150 |
T151 |
of_a |
TxB2,production |
R238 |
T69 |
T156 |
is_a |
neutrophils,adhere |
R239 |
T156 |
T154 |
to |
adhere,lung |
R240 |
T153 |
T70 |
is_a |
decrease,lymphocytes |
R241 |
T155 |
T69 |
is_a |
increase,neutrophils |
R242 |
T71 |
146 |
of_a |
vascular,inflammation |
R243 |
145 |
144 |
is_a |
TxA2,ecosanoids |
R245 |
T157 |
T40 |
is_a |
formation,thrombi |
R246 |
144 |
T157 |
relates |
ecosanoids,formation |
R247 |
144 |
146 |
cause_of |
ecosanoids,inflammation |
R248 |
144 |
147 |
cause_of |
ecosanoids,platelet aggregation |
R249 |
T75 |
T76 |
- |
platelet,aggregation |
R250 |
T152 |
T159 |
is_a |
TxB2,detected |
R251 |
T159 |
145 |
is_a |
detected,TxA2 |
R252 |
T75 |
T74 |
is_a |
platelet,thrombogenesis |
R253 |
T158 |
T74 |
is_a |
cell aggregation,thrombogenesis |
R254 |
149 |
T74 |
is_a |
clotting abnormalities,thrombogenesis |
R255 |
T78 |
T160 |
is_a |
anti-clotting inhibitor agents,prevention |
R256 |
T160 |
150 |
is_a |
prevention,thrombotic diseases |
R257 |
151 |
T161 |
is_a |
IL-1,induced |
R258 |
T161 |
T41 |
is_a |
induced,thrombi formation |
R259 |
T73 |
T162 |
of_a |
TxA2,Prevention |
R260 |
T73 |
T163 |
of_a |
TxA2,induction |
R261 |
T162 |
T164 |
is_a |
Prevention,avoids |
R262 |
T163 |
T164 |
is_a |
induction,avoids |
R263 |
T164 |
T41 |
is_a |
avoids,thrombi formation |
R264 |
T84 |
152 |
is_a |
increases,TxA2 |
R265 |
T83 |
T84 |
of_a |
significantly,increases |
R266 |
T172 |
T171 |
of_a |
serious,vascular events |
R267 |
T171 |
T41 |
coreference |
vascular events,thrombi formation |
R269 |
T165 |
T166 |
is_a |
difficult,inhibit |
R270 |
T84 |
T165 |
is_a |
increases,difficult |
R271 |
T84 |
T173 |
is_a |
increases,much better |
R272 |
T173 |
T167 |
is_a |
much better,prevent |
R273 |
T167 |
T168 |
is_a |
prevent,induction |
R274 |
T167 |
T169 |
is_a |
prevent,generation |
R275 |
153 |
T170 |
is_a |
IL-1,inductors |
R276 |
T82 |
T170 |
is_a |
blocking,inductors |
R277 |
T168 |
T82 |
is_a |
induction,blocking |
R278 |
T169 |
T82 |
is_a |
generation,blocking |
R279 |
T171 |
152 |
in |
vascular events,TxA2 |
R280 |
155 |
156 |
is_a |
death,patient |
R282 |
T174 |
155 |
is_a |
avoids,death |
R283 |
T86 |
T174 |
is_a |
inhibition,avoids |
R284 |
T87 |
T174 |
is_a |
lack,avoids |
R285 |
T87 |
T85 |
is_a |
lack,formation |
R286 |
T85 |
154 |
of_a |
formation,IL-1 |
R287 |
T86 |
T85 |
is_a |
inhibition,formation |
R288 |
T175 |
T176 |
is_a |
innate immune cells,producing |
R289 |
T176 |
157 |
is_a |
producing,IL-1 |
R290 |
159 |
158 |
abbreviation |
IL-1Ra,IL-1 receptor antagonist |
R291 |
T178 |
T177 |
is_a |
treatment,avoid |
R292 |
T177 |
T90 |
is_a |
avoid,hemodynamic changes |
R293 |
T177 |
160 |
is_a |
avoid,septic shock |
R294 |
T177 |
161 |
is_a |
avoid,inflammation |
R296 |
T178 |
T175 |
of_a |
treatment,innate immune cells |
R297 |
158 |
T178 |
with |
IL-1 receptor antagonist,treatment |
R298 |
163 |
162 |
by |
SARS-CoV-2,COVID-19 |
R299 |
T88 |
161 |
is_a |
organ,inflammation |
R31 |
121 |
120 |
cause_of |
IL-1,hypotension |
R32 |
121 |
T37 |
cause_of |
IL-1,resistance of systemic blood pressure |
R33 |
121 |
122 |
cause_of |
IL-1,leukopenia |
R34 |
121 |
123 |
cause_of |
IL-1,thrombocytopenia |
R35 |
T38 |
T42 |
cause_of |
formation of thrombi,morbidity |
R36 |
T38 |
124 |
cause_of |
formation of thrombi,mortality |
R50 |
T50 |
132 |
cause_of |
activation,thrombosis |
R51 |
T50 |
133 |
cause_of |
activation,inflammation |
R88 |
116 |
118 |
cause_of |
IL-1,pulmonary edema |
R89 |
116 |
T34 |
cause_of |
IL-1,thrombosis |
R90 |
116 |
T36 |
cause_of |
IL-1,bleeding |
R91 |
117 |
118 |
cause_of |
TNF,pulmonary edema |
R92 |
117 |
T34 |
cause_of |
TNF,thrombosis |
R93 |
117 |
T36 |
cause_of |
TNF,bleeding |
R94 |
9 |
8 |
abbreviation |
TxA2,throboxane-A2 |
R95 |
8 |
11 |
cause_of |
throboxane-A2,inflammation |
R96 |
8 |
T1 |
cause_of |
throboxane-A2,micro-thrombi |
R97 |
7 |
T93 |
is_a |
IL-1,induces |
R98 |
T93 |
8 |
is_a |
induces,throboxane-A2 |
R99 |
T95 |
T94 |
is_a |
inhibitory,effect |